Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
netFormulary
Home
Treatment Use
Class
Chapters
News
Reports
Contact
SEARCH
Searching for :
Interstitial Lung Disease
Open monograph to display formulary status.
Formulary items found
Status
Description
Section
RED
Pirfenidone 267mg Esbriet
®
(Capsules)
Respiratory system, Antifibrotics , 03.11
Searchiing the National BNF we found these items - Click button under Local to search local formulary or BNF to view on online BNF.
Local
BNF
Section
Nintedanib
Nintedanib
Respiratory System, Antifibrotics
Interstitial Lung Disease
Nintedanib
Nintedanib
Respiratory System, Antineoplastic Drugs, Protein Kinase Inhibitors
Interstitial Lung Disease
Pirfenidone
Pirfenidone
Respiratory System, Antifibrotics
Interstitial Lung Disease
Links found
NICE TA1111: Nintedanib for treating fibrosing interstitial lung disease in people 6 to 17 years (TERMINATED APPRAISAL)
NICE TA747: Nintedanib for treating progressive fibrosing interstitial lung diseases